Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

Published:2009-09 Issue:9 Volume:60 Page:2794-2804
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Giannini E. H.,Ilowite N. T.,Lovell D. J.,Wallace C. A.,Rabinovich C. E.,Reiff A.,Higgins G.,Gottlieb B.,Singer N. G.,Chon Y.,Lin S.-L.,Baumgartner S. W.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference40 articles.

1. Juvenile idiopathic arthritis;Borchers;Autoimmun Rev,2006

2. Epidemiology of chronic arthritis in childhood;Oen;Semin Arthritis Rheum,1996

3. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort;Oen;J Rheumatol,2002

5. Well-being in children with juvenile chronic arthritis;Sallfors;Clin Exp Rheumatol,2004

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies;Current Rheumatology Reports;2024-03-11

2. Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter?;Clinical Rheumatology;2024-03-05

3. Current Advances in Japanese Encephalitis Virus Drug Development;Viruses;2024-01-28

4. Comparison of biologic monotherapy versus biologic and disease-modifying anti-rheumatic drug combination in the treatment of non-systemic juvenile idiopathic arthritis;Turkish Journal of Pediatric Disease;2023-09-18

5. Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis;Rheumatology;2023-05-04